| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 114.81B | 116.08B | 103.17B | 79.87B | 82.78B | 71.25B |
| Gross Profit | 36.17B | 34.20B | 32.23B | 26.41B | 22.81B | 19.34B |
| EBITDA | 27.33B | 28.58B | 24.15B | 19.80B | 16.94B | 13.84B |
| Net Income | 16.26B | 15.99B | 14.16B | 11.92B | 11.61B | 7.42B |
Balance Sheet | ||||||
| Total Assets | 217.87B | 264.46B | 218.19B | 188.66B | 152.52B | 136.51B |
| Cash, Cash Equivalents and Short-Term Investments | 40.78B | 39.27B | 44.92B | 47.87B | 42.02B | 30.05B |
| Total Debt | 93.96B | 118.03B | 92.46B | 79.54B | 55.66B | 51.07B |
| Total Liabilities | 110.20B | 144.08B | 112.29B | 94.25B | 68.56B | 62.06B |
| Stockholders Equity | 104.02B | 119.76B | 102.19B | 90.55B | 80.73B | 71.31B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -23.89B | -8.26B | -13.46B | 9.01B | 8.96B |
| Operating Cash Flow | 0.00 | -18.04B | -4.24B | -11.00B | 16.54B | 17.44B |
| Investing Cash Flow | 0.00 | -10.29B | -8.81B | -4.21B | -6.68B | -9.38B |
| Financing Cash Flow | 0.00 | 22.20B | 9.48B | 20.99B | 2.04B | 443.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
65 Neutral | ¥1.26T | 19.14 | 13.29% | 3.25% | 24.50% | 11.52% | |
65 Neutral | ¥649.90B | 32.57 | 10.59% | 2.94% | -5.83% | -26.32% | |
62 Neutral | ¥211.44B | 7.44 | 16.39% | 2.38% | 11.56% | 14.99% | |
61 Neutral | ¥113.56B | 8.03 | 15.81% | 2.93% | 12.51% | 12.42% | |
56 Neutral | ¥825.70B | 10.45 | 7.40% | 3.68% | 24.40% | 11.46% | |
56 Neutral | ¥3.49T | 26.96 | 9.64% | 0.97% | 4.29% | 12.76% |